Although additional markers such as antithrombin III and protein C/S may provide deeper insight into the pathophysiology of sepsis-induced coagulopathy, they are not routinely available in acute care settings due to cost and logistical constraints. The gene discussed is SERPINC1; the disease is Sepsis.